AI drug developer Absci has reached a partnership with Oracle and AMD

智通財經
2025.09.11 13:14
人工智能藥物開發商 Absci 宣佈，與甲骨文和 AMD 合作，加速生成式人工智能驅動的藥物發現進程。公司的藥物發現平台將應用甲骨文的人工智能基礎設施和 AMD 的最新硬件。
Source: 智通財經 The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.